Your browser doesn't support javascript.
loading
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.
Squifflet, Pierre; Saad, Everardo D; Loibl, Sibylle; van Mackelenbergh, Marion T; Untch, Michael; Rastogi, Priya; Gianni, Luca; Schneeweiss, Andreas; Conte, Pierfranco; Piccart, Martine; Bonnefoi, Hervé; Jackisch, Christian; Nekljudova, Valentina; Tang, Gong; Valagussa, Pinuccia; Neate, Colin; Gelber, Richard; Poncet, Coralie; Heinzmann, Dominik; Denkert, Carsten; Geyer, Charles E; Cortes, Javier; Guarneri, Valentina; de Azambuja, Evandro; Cameron, David; Ismael, Gustavo; Wolmark, Norman; Cortazar, Patricia; Buyse, Marc.
Afiliação
  • Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
  • Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • van Mackelenbergh MT; German Breast Group, Neu-Isenburg, Germany.
  • Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany.
  • Rastogi P; NRG Oncology, Pittsburgh, PA.
  • Gianni L; San Raffaele Scientific Institute, Milan, Italy.
  • Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France.
  • Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany.
  • Nekljudova V; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
  • Tang G; University of Pittsburgh, Pittsburgh, PA.
  • Valagussa P; Fondazione Michelangelo, Milan, Italy.
  • Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA.
  • Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany.
  • Geyer CE; UPMC Hillman Cancer Center, Pittsburgh, PA.
  • Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom.
  • Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil.
  • Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, PA.
  • Cortazar P; Genentech, Inc, South San Francisco, CA.
  • Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
J Clin Oncol ; 41(16): 2988-2997, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36977286
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article